Orca Surgical

Solutions for Refractive Ophthalmologic Surgery

Health Tech & Life Sciences
Active
Mature Caesarea Founded 2012
Total raised
Stage
Mature
Founded
2012
Headcount
5
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

Orca Surgical develops solutions for refractive surgery, keratocounus, refractive enhancement, and recurrent erosions of the cornea. Its Epi-Bowmans Keratectomy (EBK) procedure is a new treatment paradigm for laser refractive surgery. EBK removes the epithelium in a safe, quick, and painless fashion, providing a treatment bed for both refractive surgery CXL and other applications, expediting patient recovery time. The procedure is based on the Epi Clear device, a single-use polymer epikeratome device designed to carry out precise epithelium surface removal. The device gently sweeps the epithelial surface and simultaneously collects discarded cells into the multiblade tip for thorough removal. The EBK procedure leaves clear borders that augment epithelium periphery growth in order to shorten recovery time and reduce pain during epithelial healing. The companys products are Class 1 exempt, manufactured according to international standards, and CE and AMAR approved.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Orca Surgical's primary focus in medical technology?
Orca Surgical develops solutions for refractive surgery, keratoconus, refractive enhancement, and recurrent erosions of the cornea, primarily focusing on ophthalmologic surgery.
What is the core product or procedure offered by Orca Surgical?
Orca Surgical's core offering is the Epi-Bowmans Keratectomy (EBK) procedure, which utilizes the Epi Clear device for precise epithelium surface removal in laser refractive surgery.
When was Orca Surgical founded?
Orca Surgical was founded in January 2012.
Where is Orca Surgical headquartered?
Orca Surgical is headquartered in Caesarea, Israel, with an additional office in New York, United States.
What is the regulatory status of Orca Surgical's products?
Orca Surgical's products are Class 1 exempt, manufactured according to international standards, and have received CE and AMAR approval.
What is the reported patient experience with Orca Surgical's epi-Bowman keratectomy procedure?
In November 2017, patients reported less pain and discomfort with Orca Surgical's epi-Bowman keratectomy procedure, according to news from healio.com.
What markets does Orca Surgical target geographically?
Orca Surgical targets the United States and Europe as its geographic markets.
What is the current employee count for Orca Surgical?
Orca Surgical currently has 5 employees.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

surgerymedical-deviceseye-diseasesophthalmologysurgical-instrumentssurgeonsclinicshospitals